
11 - 50 employees
Founded 2024
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
💰 $300M Venture Round - GondolaBio on 2024-08
Healthcare • Consulting • Manufacturing
GondolaBio is a clinical-stage biopharmaceutical company launched in 2024 and affiliated with BridgeBio Pharma, focused on developing breakthrough therapeutics for patients with genetic diseases. The company uses a lean, decentralized approach to accelerate early-stage research and development across multiple modalities (including small molecules and oligonucleotide therapies) and is building a diverse pipeline targeting rare and underserved genetic conditions such as EPP/XLP with its lead program PORT-77. GondolaBio centers patient needs and aims to bring disease-modifying treatments more quickly to populations lacking approved therapies.
🕒 June 16
Improve your chances of getting an interview by checking your resume score before you apply.

11 - 50 employees
Founded 2024
🏥 Healthcare
💼 Consulting
🏭 Manufacturing
💰 $300M Venture Round - GondolaBio on 2024-08
Healthcare • Consulting • Manufacturing
GondolaBio is a clinical-stage biopharmaceutical company launched in 2024 and affiliated with BridgeBio Pharma, focused on developing breakthrough therapeutics for patients with genetic diseases. The company uses a lean, decentralized approach to accelerate early-stage research and development across multiple modalities (including small molecules and oligonucleotide therapies) and is building a diverse pipeline targeting rare and underserved genetic conditions such as EPP/XLP with its lead program PORT-77. GondolaBio centers patient needs and aims to bring disease-modifying treatments more quickly to populations lacking approved therapies.
• Serve as the global regulatory lead for assigned development programs, defining stage-appropriate regulatory strategies and development pathways. • Develop regulatory strategy for rare disease and accelerated development programs, including orphan designation applications and expedited development pathways. • Partner closely with Clinical Development, Translational Sciences, Nonclinical, CMC, and other functional teams, including working with CROs as needed, to integrate regulatory considerations into development planning and key program decisions. • Provide strategic regulatory input on study design, translational biomarkers, dose selection, and first-in-human safety considerations. • Provide regulatory guidance to support efficient and informed decision-making while balancing development speed, scientific rigor, and long-term program optionality. • Lead preparation for and interactions with global health authorities, including briefing documents, meeting strategy, and written correspondence. • Lead and contribute directly to the planning, preparation, and submission of high-quality regulatory submissions (e.g., IND, CTA), amendments, annual reports, and other regulatory filings. • Maintain awareness of evolving regulatory guidance and industry trends that may impact development strategies. • Support global development efforts by evaluating regional regulatory requirements and opportunities.
• Advanced degree in a scientific discipline (Ph.D., Pharm.D., M.D., or equivalent) preferred. • For Associate Director, we expect 7+ years of pharmaceutical/biotechnology industry experience, at least 6 of which should be regulatory experience; for Director, we expect 10+ years of pharmaceutical/biotechnology industry experience, at least 8 of which should be regulatory experience. • Demonstrated record of regulatory success, including leading and supporting IND-stage programs through key regulatory milestones and supporting advancement through development. • Experience with rare diseases and familiarity with accelerated or expedited regulatory pathways. • Proven track record leading and supporting interactions with regulatory authorities, including briefing documents, meetings, and written responses. • Strong understanding of early clinical development, translational biomarkers, and first-in-human safety considerations. • Strong cross-functional leadership and communication (written and verbal) skills.
• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts • A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak • An unyielding commitment to always putting patients first • A decentralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science • A place where you own the vision – both for your program and your own career path • A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game • Access to learning and development resources to help you get in the best professional shape of your life • Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs) • Flexible PTO • Rapid career advancement for strong performers • Potential ability to work on multiple GondolaBio Pharma programs across multiple therapeutic areas over time • Commitment to Diversity, Equity & Inclusion
Apply Now🕒 June 16
Regional Compliance Specialist responsible for compliance of housing projects for Monroe Group. Evaluate agency requirements and implement compliance procedures across properties in the portfolio.
🕒 June 16
Senior Trade Compliance Analyst managing daily execution of trade compliance activities for global import/export. Leading operational management and customs compliance for U.S. and Mexican cross-border operations.
🕒 June 15
Compliance Analyst managing policy compliance and product filings for Crum & Forster’s A&H division. Preparing insurance documents and ensuring adherence to regulations and company guidelines.
🕒 June 14
Lead and elevate global quality, compliance, and regulatory functions within beauty and cosmetics industry. Oversee team, engage in hands-on functions and ensure compliance with regulations.
🕒 June 13
Senior Director of Regulatory CMC providing strategic leadership for radiopharmaceutical compliance and regulatory submissions. Partnering with teams to ensure CMC readiness across all development stages.